• Ticker

DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$22.54 -$0.12 (-0.53%)

REAL-TIME: Last trade at

Acorda Therapeutics, Inc.

NASDAQ:ACOR

6 Small Cap Stocks With Plenty Of Cash On Hand And Strong Expected Growth

Revenues Climb at Acorda - Analyst Blog

Zacks #1 Rank Additions for Tuesday - Tale of the Tape

Biogen's Fampyra Launched in Canada - Analyst Blog

Will the FDA Approve Chelsea's Northera?

Earnings Beat for Acorda - Analyst Blog

3 Biotech Buyout Candidates for 2012

US Stock Futures: HOT STOCKS TO WATCH

Big Potential? Takeover Targets With Solid Profitability

Biogen Idec Passes This Key Test

Modest Growth, Less-Than-Modest Stock Drop

After Hours: Dendreon's Shares Crushed Again

Invest in Biotechs Going After Unmet Needs

Brain Disorders: 3 Biotech Stocks at the Forefront

Afternoon Roundup: Today's Top Stories

Biogen, Acorda MS Drug Gets Conditional European Approval

Acorda To Pay Up To $35 Million To Medtronic In Licensing Deal

Acorda Pushes Sales of MS Drug

Options Ideas: 24 Healthcare Stocks With Bullish Options Sentiment

UPDATE: Biogen, Acorda MS Drug Gets EU Backing After Appeal

Acorda Rises on European Surprise

Top Biotech Picks by Hedge Fund and Mutual Fund Gurus Concentrated in the Sector

Alkermes Bulks Up With Elan

Analyzing Seeking Alpha's Top Gainers and Losers Using Levered Free Cash Flow

Squeeze Ideas: 17 Short Seller Targets for a Watchlist

14 Companies Near Lows With Enough Cash to Cover More Than a Year's Expenses

6 Biotech Firms With Encouraging DuPont Breakdowns

Analyst Calls: BRCD, CREE, DUK, HRL, MOLX, RTN, SPWRA, VCLK, WTW ...

Friday Options Brief: TYC, JWN, ACOR & MRO

Do Mergers Mean Billions for Biotech?

Do Mergers Means Billions for Biotech?

Short Ideas: 14 Highly Shorted Stocks With Rising Inventories

Weekend Research: 17 Stocks Hitting New Lows on January 21, 2011

UPDATE: Europe Panel Rejects Biogen, Acorda MS Drug

Friday Options Brief: CHBT, JPM, ACOR & PLCM

18 Small Cap Stocks Targeted by Short Sellers

The Top 20 Most Undervalued Healthcare Stocks By Target Price

Biogen Gets Letter Of Deficiency From Health Canada On Fampridine

Analyst Calls: AA, AAPL, ATHR, BKS, CL, CLX, EL, HBAN, NCR, NVDA, XRTX ...

Wall Street Breakfast: Must-Know News

See More Articles...